590 related articles for article (PubMed ID: 29959474)
1. Expression of IL-17F is associated with non-pathogenic Th17 cells.
Wanke F; Tang Y; Gronke K; Klebow S; Moos S; Hauptmann J; Shanmugavadivu A; Regen T; Mufazalov IA; Gabriel LA; Reißig S; Diefenbach A; Kurschus FC; Waisman A
J Mol Med (Berl); 2018 Aug; 96(8):819-829. PubMed ID: 29959474
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: an IL-17F-CreEYFP reporter mouse allows fate mapping of Th17 cells.
Croxford AL; Kurschus FC; Waisman A
J Immunol; 2009 Feb; 182(3):1237-41. PubMed ID: 19155467
[TBL] [Abstract][Full Text] [Related]
3. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.
Wang Y; Xing F; Ye S; Xiao J; Di J; Zeng S; Liu J
Sci Rep; 2015 Feb; 5():8234. PubMed ID: 25648768
[TBL] [Abstract][Full Text] [Related]
4. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
6. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
7. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
8. TH17 cell induction and effects of IL-17A and IL-17F blockade in experimental colitis.
Wedebye Schmidt EG; Larsen HL; Kristensen NN; Poulsen SS; Lynge Pedersen AM; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2013 Jul; 19(8):1567-76. PubMed ID: 23689808
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells.
McGinley AM; Sutton CE; Edwards SC; Leane CM; DeCourcey J; Teijeiro A; Hamilton JA; Boon L; Djouder N; Mills KHG
Immunity; 2020 Feb; 52(2):342-356.e6. PubMed ID: 32023490
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IL-17A production is distinct from IL-17F in a primary human cell co-culture model of T cell-mediated B cell activation.
Melton AC; Melrose J; Alajoki L; Privat S; Cho H; Brown N; Plavec AM; Nguyen D; Johnston ED; Yang J; Polokoff MA; Plavec I; Berg EL; O'Mahony A
PLoS One; 2013; 8(3):e58966. PubMed ID: 23505568
[TBL] [Abstract][Full Text] [Related]
11. The IL17A and IL17F loci have divergent histone modifications and are differentially regulated by prostaglandin E2 in Th17 cells.
Adamik J; Henkel M; Ray A; Auron PE; Duerr R; Barrie A
Cytokine; 2013 Oct; 64(1):404-12. PubMed ID: 23800789
[TBL] [Abstract][Full Text] [Related]
12. Genetic proof for the transient nature of the Th17 phenotype.
Kurschus FC; Croxford AL; Heinen AP; Wörtge S; Ielo D; Waisman A
Eur J Immunol; 2010 Dec; 40(12):3336-46. PubMed ID: 21110317
[TBL] [Abstract][Full Text] [Related]
13. A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells.
Fujie H; Niu K; Ohba M; Tomioka Y; Kitazawa H; Nagashima K; Ohrui T; Numasaki M
Inflammation; 2012 Jun; 35(3):1119-31. PubMed ID: 22219048
[TBL] [Abstract][Full Text] [Related]
14. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment.
Liang SC; Long AJ; Bennett F; Whitters MJ; Karim R; Collins M; Goldman SJ; Dunussi-Joannopoulos K; Williams CM; Wright JF; Fouser LA
J Immunol; 2007 Dec; 179(11):7791-9. PubMed ID: 18025225
[TBL] [Abstract][Full Text] [Related]
15. [Generation of engineering Th17 cells and its function evaluation].
Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
[TBL] [Abstract][Full Text] [Related]
16. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s.
Matsuzaki G; Umemura M
Microbiol Immunol; 2018 Jan; 62(1):1-13. PubMed ID: 29205464
[TBL] [Abstract][Full Text] [Related]
18. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
Reppert S; Zinser E; Holzinger C; Sandrock L; Koch S; Finotto S
Eur J Immunol; 2015 May; 45(5):1426-40. PubMed ID: 25689841
[TBL] [Abstract][Full Text] [Related]
19. IL-17 controls central nervous system autoimmunity through the intestinal microbiome.
Regen T; Isaac S; Amorim A; Núñez NG; Hauptmann J; Shanmugavadivu A; Klein M; Sankowski R; Mufazalov IA; Yogev N; Huppert J; Wanke F; Witting M; Grill A; Gálvez EJC; Nikolaev A; Blanfeld M; Prinz I; Schmitt-Kopplin P; Strowig T; Reinhardt C; Prinz M; Bopp T; Becher B; Ubeda C; Waisman A
Sci Immunol; 2021 Feb; 6(56):. PubMed ID: 33547052
[TBL] [Abstract][Full Text] [Related]
20. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.
Huber M; Heink S; Pagenstecher A; Reinhard K; Ritter J; Visekruna A; Guralnik A; Bollig N; Jeltsch K; Heinemann C; Wittmann E; Buch T; Prazeres da Costa O; Brüstle A; Brenner D; Mak TW; Mittrücker HW; Tackenberg B; Kamradt T; Lohoff M
J Clin Invest; 2013 Jan; 123(1):247-60. PubMed ID: 23221338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
